BME:MVCReal Estate
Metrovacesa (BME:MVC) Stock Faces 257.9% Earnings Surge Questioning Bearish Narratives
Metrovacesa (BME:MVC) has put fresh numbers on the table for H1 2026, with trailing twelve month revenue of €891.3 million and Basic EPS of €0.59, alongside year-on-year earnings growth of 257.9%. Over recent periods, revenue has moved from €422.7 million in H2 2024 to €575.8 million in H2 2025, while EPS shifted from €0.08 to €0.48 over the same halves. This sets up a very different earnings profile to just a year ago. With the net margin for the trailing period at 8% versus 2.4% in the...